• Mashup Score: 3

    A combination of two drugs showed promising phase 2 results, including a reduction in cognitive impairment in patients with lacunar stroke, and may be a potential new approach to small vessel disease.

    Tweet Tweets with this article
    • #ISC23 Drug combo has shown promising results, including a reduction in cognitive impairment in patients who have had a lacunar stroke, and is seen as a new therapeutic approach for patients with cerebral small vessel disease. https://t.co/TjRpyeAhSR

  • Mashup Score: 0

    The goal of reducing variation across stroke centers at different levels is to improve patient care and outcomes, an author says.

    Tweet Tweets with this article
    • "Every stroke program can probably take a little piece of this, at least, and work on it to improve their program in some way," @WDusenbury says #ISC23 @TCTMD @American_Stroke @American_Heart https://t.co/VQxZFGb9Vl

  • Mashup Score: 0
    Wolters Kluwer Health - 1 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…

    Tweet Tweets with this article
    • Via #ISC23: Using medication to keep systolic #BloodPressure lower after successful endovascular procedures for acute ischemic #stroke might pose a risk of harm: https://t.co/F82YoBL1wW #neurotwitter @AANMember@American_Heart @eva_mistry https://t.co/hbwJHqC6T9

  • Mashup Score: 0

    February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic cardiovascular disease, presented data from a recent large animal study performed by VST-Bio and Yale University demonstrating that a single iv bolus of VST-002 led to meaningful reduction in brain damage and improved function in an advanced model of ischemic stroke.  Dr. Federico…

    Tweet Tweets with this article
    • @DAICeditor @American_Stroke VST-Bio presented data from an animal study performed by #VST_Bio and #Yale_University demonstrating a single iv bolus of VST-002 led to meaningful reduction in #braindamage and improved function in #ischemic_stroke: https://t.co/VhCZhRlJja #ISC23

  • Mashup Score: 4

    Preliminary results of a new study showed that using an antihypertensive drug to target systolic blood pressure to below 160 mm Hg or 140 mm Hg in these patients may not be beneficial, and may even be harmful.

    Tweet Tweets with this article
    • Artificially lowering blood pressure in stroke patients following endovascular therapy is not necessarily a good strategy, new research suggests. #ISC23 https://t.co/RN9h5PBAds